LP-168 and Obinutuzumab for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Variants of This
Clinical trial NCT06978088 · RECRUITING
Trial details
- NCT number
- NCT06978088
- Sponsor
- Zulfa Omer
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-01
- Primary completion
- 2029-06-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.